Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,554.00INR
3:22pm IST
Price Change (% chg)

Rs14.65 (+0.58%)
Prev Close
Rs2,539.35
Open
Rs2,540.00
Day's High
Rs2,570.95
Day's Low
Rs2,524.75
Volume
15,151
Avg. Vol
25,577
52-wk High
Rs2,939.80
52-wk Low
Rs1,860.00

REDY.BO

Chart for REDY.BO

About

Dr. Reddy’s Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active... (more)

Overall

Beta: 0.51
Market Cap (Mil.): Rs431,523.69
Shares Outstanding (Mil.): 170.11
Dividend: 15.00
Yield (%): 0.59

Financials

  REDY.BO Industry Sector
P/E (TTM): 19.31 32.56 32.65
EPS (TTM): 131.40 -- --
ROI: -- 19.75 19.01
ROE: -- 20.45 19.78
Search Stocks

MARKET EYE-Indian drugmakers hit by worries about Russia, Ukraine sales

* Shares in Indian drugmakers fall, with Dr Reddy's Laboratories down 1.9 percent, on concerns that sales in Russia and Ukraine will be hit given military tensions between the two countries. * Dr. Reddy's has the highest exposure to Russia and former Soviet republics, with the region comprising 14.5 percent of sales, Bank of America-Merrill Lynch says in a note dated on Monday. * Ranbaxy Laboratories Ltd and Glenmark Pharmaceuticals Ltd also have exposure to Russia and former Soviet republics,

04 Mar 2014

Dr Reddy's hits record high on migraine drug launch in U.S.

Reuters Market Eye - Shares in Dr Reddy's Laboratories rose as much as 2.1 percent to a record high on growing hopes about its U.S. business.

26 Feb 2014

IDFC, Dr. Reddy's earnings may beat estimates - StarMine

Reuters Market Eye - IDFC Ltd and Dr. Reddy's Laboratories Ltd may beat July-September earnings consensus forecast when they report results later in the day, according to Thomson Reuters StarMine data.

31 Oct 2013

MARKET EYE-India's IDFC, Dr.Reddy's earnings may beat estimates-StarMine

* IDFC Ltd and Dr.Reddy's Laboratories Ltd may beat July-September earnings consensus forecast when they report results later in the day, according to Thomson Reuters StarMine data. * StarMine's SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, expects IDFC to report a profit of 4.99 billion Indian rupees ($81.41 million) for the quarter, compared with a wider consensus mean estimate of 4.81 billion rupees. * Dr.Reddy's is expected to report a profit of 4.73 bil

31 Oct 2013

India's BSE index ends at record high; foreign-led rally helps

* BSE and NSE index gain 0.5 pct each * Telecom shares surge on strong operating performance * Dr.Reddy's marks all-time high a day ahead of earnings By Abhishek Vishnoi MUMBAI, Oct 30 - India's benchmark BSE index closed at a record high on Wednesday as telecoms firms such as Bharti Airtel surged after reporting higher margins, while continued foreign inflows boosted sentiment. The BSE index has now gained 21 percent since hitting an intraday yearly low of 17,448.

30 Oct 2013

Earnings vs. Estimates

Search Stocks